Skip to main content

Table 5 Significant items/recommendations between a definite gout and diagnosis only by ICD-10

From: Quality of gout care in the emergency departments: a multicentre study

Items/recommendations

Total

N (%) (n = 632)

Definite gouta

N (%) (n = 266)

ICD-10 N (%)

(n = 366)

Investigations in EDs

- Complete blood count**

265 (41.9)

152 (57.1)

113 (30.9)

- Renal function test**

302 (47.8)

161 (60.5)

141 (38.5)

Arthrocentesis**

185 (29.3)

161 (60.5)

24 (6.6)

Consultation**

157 (24.8)

105 (39.5)

52 (14.2)

Average time in EDs**, hour, mean (±SD)

2.16 (2.16) (n = 369)

3.05 (2.72) (n = 162)

1.46 (1.19) (n = 207)

Monotherapy of colchicine

- In EDs*

167/628 (26.6)

93/265 (35.1)

74/363 (20.4)

- In HM*

186/519 (35.8)

91/204 (44.6)

95/315 (30.2)

NSAIDsb can be used in early or late treatment of GF.

- In EDs*

343/628 (54.6)

121/265 (45.7)

222/363 (61.2)

NSAIDsb should be used in normal renal function.

- In EDs*

183/343 (53.4)

85/121 (70.5)

98/222 (44.1)

NSAIDsb were used in unevaluated renal function.

- In EDs**

118/343 (34.4)

21/121 (17.4)

97/222 (43.7)

- In HM*

95/276 (34.4)

17/96 (17.7)

78/180 (43.3)

All patients who have improved after acute GF should have an appointment to follow up for evaluation of the risks or factors that can affect SUA and to evaluate complication of gout disease*.

436/632 (69.0)

216/266 (81.2)

220/366 (60.1)

  1. EDs Emergency departments, HM home medications, NSAIDs Non-steroidal anti-inflammatory drugs, GF Gout flare, SUA Serum uric acid
  2. p value was compared between definite gout and ICD-10 group
  3. * p value< 0.05, ** p value< 0.001
  4. aDefinite diagnosis of gout was made if MSU crystals in synovial fluid as identified in the EDs or at least a score of 8 according the ACR/EULAR classification criteria.
  5. bIncluding monotherapy and combination therapy.